Chris Kosmidis

5.8k total citations · 1 hit paper
77 papers, 2.3k citations indexed

About

Chris Kosmidis is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chris Kosmidis has authored 77 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 43 papers in Epidemiology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chris Kosmidis's work include Antifungal resistance and susceptibility (42 papers), Fungal Infections and Studies (30 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers). Chris Kosmidis is often cited by papers focused on Antifungal resistance and susceptibility (42 papers), Fungal Infections and Studies (30 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers). Chris Kosmidis collaborates with scholars based in United Kingdom, Greece and United States. Chris Kosmidis's co-authors include David W. Denning, George L. Daikos, Glenn W. Kaatz, Susan M. Seo, Panayotis T. Tassios, Diixa Patel, Chris Harris, Mina Psichοgiou, G. Petrikkos and L. S. Tzouvelekis and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Chris Kosmidis

72 papers receiving 2.2k citations

Hit Papers

The clinical spectrum of pulmonary aspergillosis 2014 2026 2018 2022 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The clinical spectrum of pulmonary aspergillosis
    2014 558 citations Chris Kosmidis, David W. Denning profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Kosmidis United Kingdom 25 1.2k 1.1k 504 424 265 77 2.3k
F. Jacobs Belgium 26 1.1k 0.9× 1.2k 1.1× 510 1.0× 271 0.6× 426 1.6× 62 2.5k
Charalampos Antachopoulos Greece 28 1.3k 1.0× 1.3k 1.1× 547 1.1× 152 0.4× 260 1.0× 79 2.4k
Masafumi Seki Japan 27 789 0.6× 1.2k 1.1× 217 0.4× 366 0.9× 453 1.7× 155 2.5k
Y. J. Debets-Ossenkopp Netherlands 23 1.4k 1.1× 1.1k 1.0× 267 0.5× 246 0.6× 205 0.8× 38 2.4k
Carlota Gudiol Spain 31 1.0k 0.8× 1.4k 1.3× 746 1.5× 228 0.5× 192 0.7× 95 3.1k
Taiga Miyazaki Japan 29 1.7k 1.3× 1.5k 1.4× 153 0.3× 326 0.8× 536 2.0× 177 2.7k
Sofía Perea United States 22 1.2k 1.0× 1.2k 1.1× 110 0.2× 283 0.7× 329 1.2× 73 2.4k
K. V. I. Rolston United States 34 1.0k 0.8× 1.5k 1.4× 374 0.7× 335 0.8× 285 1.1× 86 3.5k
Jacques Tankovic France 26 522 0.4× 653 0.6× 719 1.4× 208 0.5× 468 1.8× 57 2.1k
Soon‐Pal Suh South Korea 28 1.6k 1.3× 1.4k 1.3× 120 0.2× 171 0.4× 625 2.4× 177 3.0k

Countries citing papers authored by Chris Kosmidis

Since Specialization
Citations

This map shows the geographic impact of Chris Kosmidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Kosmidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Kosmidis more than expected).

Fields of papers citing papers by Chris Kosmidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Kosmidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Kosmidis. The network helps show where Chris Kosmidis may publish in the future.

Co-authorship network of co-authors of Chris Kosmidis

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Kosmidis. A scholar is included among the top collaborators of Chris Kosmidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Kosmidis. Chris Kosmidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Denning, David W. & Chris Kosmidis. (2025). Chronic Pulmonary Aspergillosis Is a Differential Diagnosis and Co-infection With Nontuberculous Mycobacterial Pulmonary Disease. Clinical Infectious Diseases. 81(3). e53–e55.
3.
Ocansey, Bright, et al.. (2024). A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study. Medical Mycology. 62(3). 2 indexed citations
4.
Wang, Ran, et al.. (2023). Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma. Medical Mycology. 61(8). 1 indexed citations
5.
Nurwidya, Fariz, Jamal Zaini, Findra Setianingrum, et al.. (2023). The Fungal and Bacterial Interface in the Respiratory Mycobiome with a Focus on Aspergillus spp.. Life. 13(4). 1017–1017. 8 indexed citations
6.
Boccabella, Cristina, Ekaterina Khaleva, Graham Roberts, et al.. (2023). Prevalence and clinical implications of respiratory viruses in asthma during stable disease state and acute attacks: Protocol for a meta-analysis. PLoS ONE. 18(11). e0294416–e0294416.
7.
Sprute, Rosanne, Eva Van Braeckel, Holger Flick, et al.. (2022). EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis. Journal of Antimicrobial Chemotherapy. 78(1). 225–231. 16 indexed citations
8.
9.
Ocansey, Bright, et al.. (2022). Chronic pulmonary aspergillosis is common among patients with presumed tuberculosis relapse in Ghana. Medical Mycology. 60(9). 14 indexed citations
10.
Ocansey, Bright, Vincent Ganu, Fleischer C. N. Kotey, et al.. (2022). Cryptococcal and Histoplasma Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx Histoplasma Lateral Flow Assay and IMMY Histoplasma Enzyme Immunoassay. Open Forum Infectious Diseases. 9(7). ofac277–ofac277. 27 indexed citations
11.
Ocansey, Bright, Chris Kosmidis, Améyo M. Dorkenoo, et al.. (2022). Histoplasmosis in Africa: Current perspectives, knowledge gaps, and research priorities. PLoS neglected tropical diseases. 16(2). e0010111–e0010111. 23 indexed citations
12.
Chronopoulos, Efstathios, et al.. (2021). Prevalence of morphometric vertebral fractures in osteoporotic patients in Greece: the Vertebral Integrity Assessment (VERTINAS) study. Archives of Osteoporosis. 16(1). 165–165. 2 indexed citations
13.
Makras, Polyzois, George C. Babis, Efstathios Chronopoulos, et al.. (2020). Experience gained from the implementation of the fracture liaison service in Greece. Archives of Osteoporosis. 15(1). 12–12. 6 indexed citations
14.
Al-shair, Khaled, Eavan G. Muldoon, Julie Morris, et al.. (2016). Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA). Respiratory Medicine. 114. 117–122. 14 indexed citations
15.
Kosmidis, Chris, A Markogiannakis, Dimitris Goukos, et al.. (2013). Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns. Journal of Chemotherapy. 25(4). 217–221. 3 indexed citations
16.
Nikou, George, Christos Toubanakis, Konstantinos G. Moulakakis, et al.. (2011). Carcinoid tumors of the duodenum and the ampulla of Vater: Current diagnostic and therapeutic approach in a series of 8 patients. Case series. International Journal of Surgery. 9(3). 248–253. 27 indexed citations
17.
Kosmidis, Chris, Mina Psichοgiou, Panayotis T. Tassios, et al.. (2009). Prospective study of Klebsiella pneumoniae bacteremia:Risk factors and clinical significance of type VIM-1 metallo-beta-lactamases. Research Explorer (The University of Manchester). 2 indexed citations
18.
Vasilakopoulou, Alexandra, Mina Psichοgiou, L. S. Tzouvelekis, et al.. (2009). Prevalence and Characterization of Class 1 Integrons in Escherichia coli of Poultry and Human Origin. Foodborne Pathogens and Disease. 6(10). 1211–1218. 21 indexed citations
19.
Nikou, George, K. Marinou, P. Thomakos, et al.. (2008). Chromogranin A Levels in Diagnosis, Treatment and Follow-Up of 42 Patients with Non-Functioning Pancreatic Endocrine Tumours. Pancreatology. 8(4-5). 510–519. 64 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Jacobs Breakdown of academic impact, for papers by Charalampos Antachopoulos Breakdown of academic impact, for papers by Masafumi Seki Breakdown of academic impact, for papers by Y. J. Debets-Ossenkopp Breakdown of academic impact, for papers by Carlota Gudiol Breakdown of academic impact, for papers by Taiga Miyazaki Breakdown of academic impact, for papers by Sofía Perea Breakdown of academic impact, for papers by K. V. I. Rolston Breakdown of academic impact, for papers by Jacques Tankovic Breakdown of academic impact, for papers by Soon‐Pal Suh
Rankless by CCL
2026